Ketorolac vs. morfina nel trattamento del dolore acuto in pazienti traumatizzati: un’analisi di minimizzazione dei costi

Ketorolac vs. morfina nel trattamento del dolore acuto in pazienti traumatizzati: un’analisi di minimizzazione dei costi

Authors

  • G.L. Colombo Valutazioni Economiche, Milano

  • B. Borghi Ospedale Rizzoli,Bologna

  • M. Caruggi Unità di Terapia del Dolore, Ospedale S. Leonardo, Castellammare di Stabia, Napoli

  • A. De Nicola Azienda Ospedaliera “Ospedale Civile di Legnano”, Legnano



DOI:

https://doi.org/10.7175/fe.v2i2.723

Abstract

Aim of this study is to develop an economic valuation comparing ketorolac vs. morphine for the treatment of sharp pain caused by heavy limb injury, in traumatology ward and in first aid ward. As cost minimization analysis, this economic valuation has been based on clinical results of Rainer et al. (2000). Ketorolac and morphine have the same efficacy in calming the pain; the greatest difference in the clinical outcomes is about the morphine side effects (nausea, vomiting and phlebitis). Assuming the hospital point of view with a differential costs perspective, the ketorolac patients showed two consequences than could generate lower resources consumption: less side effects and the reduction of time permanence in first aid ward. Considering the drug cost, the administration cost and the side effects treatment costs, the expenditure for every single morphine patient is L. 23.385, vs L. 4.875 for a ketorolac patient, with a difference of L. 18.510.

Downloads

Published

2001-06-15

How to Cite

Colombo, G., Borghi, B., Caruggi, M., & De Nicola, A. (2001). Ketorolac vs. morfina nel trattamento del dolore acuto in pazienti traumatizzati: un’analisi di minimizzazione dei costi. Farmeconomia. Health Economics and Therapeutic Pathways, 2(2), 91–98. https://doi.org/10.7175/fe.v2i2.723

Issue

Vol. 2 No. 2 (2001)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)